For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.
Every so often, ayahuasca returns to the headlines, courts, and public debates in Europe. Seizures, criminal proceedings, acquittals, and closed cases coexist in a confusing legal landscape, marked more by prohibitionist inertia than by a careful analysis of current law.
The use of ayahuasca has grown exponentially in non-traditional contexts, generating unprecedented interest in its potential therapeutic and spiritual benefits. However, this boom has also
A new ICEERS report estimates the number of people drinking ayahuasca worldwide and analyzes fatalities reported by the media.
The 68th session of the United Nations Commission on Narcotic Drugs (CND) took place between March 10th and 14th. An event in which governments, international organizations and civil society meet to review and follow up on the international drug control treaties, outline drug policy guidelines, and share new challenges and opportunities.
On March 13, ICEERS held a virtual seminar entitled “Ayahuasca and Safety: A Multidisciplinary Approach to Ceremonial Work in Non-native Contexts”, a meeting that brought together virtually fifty participants from various countries.
From January 25 to 30, 2025, in the Sacred Village of the Yawanawa people, in the Indigenous land Rio Gregório, in Acre, Brazil, the V Indigenous Ayahuasca Conference was held.
On February 11, 2025, ICEERS organized a webinar entitled “Testimonies of legal cases around ayahuasca.” The event brought together people who have faced legal proceedings for ayahuasca use and members of ICEERS’ legal and scientific team, who provided them with support through the Ayahuasca Defense Fund (ADF).
It is with great sadness that we share the passing of our dear colleague Ricard Faura Cantarell, who died in the early hours of January 18, 2025. His departure leaves a deep and irreplaceable void, not only among those of us who had the privilege of working with him, but also in the countless fields to which he contributed with passion, dedication, and wisdom.
A study conducted in Catalonia by ICEERS and the Sant Joan de Reus University Hospital has published preliminary results showing how the use of low-dose ibogaine can reduce methadone tolerance in patients with opioid dependence.
Today, January 14, 2025, the collection of signatures has begun for the European citizens’ initiative PsychedeliCare, a proposal that seeks to promote the regulation of therapies assisted with traditional medicines in Europe’s public health systems.
Fuertedélica, the third edition of an international conference that has already become a global reference in the field of psychedelics and their potential to alleviate mental health disorders.
On the occasion of ICEERS’ 15th anniversary, we asked its founder, Benjamin De Loenen, to take stock of the foundation’s trajectory. In addition, we delve into the current and future challenges facing the historical process of globalization of master plants and their ceremonial practices.
In recent days, cannabis social clubs (CSCs) in Barcelona have faced a series of administrative inspections resulting in economic sanctions and, in some cases, closure orders. This situation, driven by the new mayor Jaume Collboni from the Socialist Party of Catalonia, threatens to dismantle a model internationally recognized as a safe and responsible alternative to the unregulated cannabis market.
The 2024 International Conference on Psychedelic Research (ICPR) in the Netherlands gathered international experts across various subject areas. ICEERS helped coordinate a panel discussion that examined the various challenges facing the so-called “Psychedelic Renaissance” along with representatives from PsyPan, LIAAN, and MovAya.
A recent report by Dr. Tlaleng Mofokeng, the UN Special Rapporteur on the right to health, titled “Drug Use, Harm Reduction and the Right to Health,” provides a thorough analysis of human rights protection within drug policy and emphasizes the preservation of Traditional Indigenous Medicines.
Claude Bauchet is a key figure in the Santo Daime community in France. He has faced significant legal challenges since 2005 when ayahuasca was classified as a controlled substance by the French Ministry of Interior. Despite the lack of evidence supporting its classification as a narcotic, Claude Bauchet was arrested again in 2019 and is now facing multiple charges.
After a decade of experience at the ICEERS Support Center and supporting over 1,000 cases following difficult psychedelic experiences, Marc B. Aixalà has become a global reference in the field of psychedelic integration.
ICEERS interviewed Joshua Bloom after his accomplishment to learn more about advocacy work for plant medicine, what it was like to complete the ultramarathon, and his hopes for the future.
A new report by ICEERS thoroughly examines the legal framework surrounding ayahuasca in Portugal and discusses its implications.
Sharing circles after a psychedelic experience involve being in a supportive and non-judgmental group setting, where participants take turns sharing their personal experiences without reconveying the experience in great detail.
With the arrival of a new mayor of Barcelona, Jaume Collboni (PSC) and his governing team, there has been a significant shift in the city’s policy towards Cannabis Social Clubs (CSCs).
Intercultural health is emerging as a transformative approach to healthcare, integrating Western medical practices with traditional Indigenous healing methods.
Seventy health professionals, scientists, scholars, and aficionados of altered states of consciousness gathered in Corralejo, Fuerteventura, for the 2nd Annual Fuerteventura Psychedelic Conference. The event was organized by the Psychedelic Association Fuerteventura with the support of ICEERS.
Psilocybin mushrooms are explicitly included in Schedule 1 of prohibited psychotropic substances in Mexico, characterized as those with scant or no therapeutic value and posing a serious threat to public health despite the country being the origin of their medicinal applications, from which their application has spread worldwide.
